1) Patients with a history of hypersensitivity to Ciclesonide2) Except for COVID-19, who have infectious disease or deep mycosis without an effective antibacterial agent3) Patients using inhaled or oral steroids4) Patients with fever of 37.5 degrees for 7 days 5) Patients co-administering treatments that may have therapeutic effects on COVID-196) Patients who are considered inappropriate for inclusion in the study by the investigator

1) Patients with a history of hypersensitivity to Ciclesonide2) Except for COVID-19, who have infectious disease or deep mycosis without an effective antibacterial agent3) Patients using inhaled or oral steroids4) Patients with fever of 37.5 degrees for 7 days 5) Patients co-administering treatments that may have therapeutic effects on COVID-196) Patients who are considered inappropriate for inclusion in the study by the investigator